This publication has been discontinued on July 19, 2011.
Abstract
The depression therapy market is one of the largest in the world. Several
antidepressants have achieved blockbuster status. Although the market for
antidepressants continues to grow, the rate of growth has slowed, in part
because of generics competition. By 2010, the market-leading antidepressants
will all face generics competition, at least in the United States. In this
report, we examine the current antidepressant market and discuss the effect
that increasing generics competition will have.
Table of Contents
Introduction
Depression: Disease Burden, Characteristics, and Prevalence
Current Antidepressant Market
Impact of Generics on Branded Drugs:Case Studies
Key Impending Patent Expiries
Antidepressants in Development
Market Outlook
